Emergent BioSolutions Inc (NYSE:EBS)
| 33.74 Delayed Data As of 4:00pm ET |  +0.405 / +1.22%Today’s Change | 27.61 Today|||52-Week Range 68.03 | -22.39% Year-to-Date |
Institutional investors purchased a net $1.2 million shares of EBS during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 84.23% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Mutual fund holders | 53.13% |
| Other institutional | 31.11% |
| Individual stakeholders | 24.54% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 3/31/2022 | JACOBS LEVY EQUITY MANAGEMENT, I... Bought 503.3 Thousand shares of Emergent BioSolutions Inc |
| 3/31/2022 | SSGA FUNDS MANAGEMENT, INC. Bought 436.7 Thousand shares of Emergent BioSolutions Inc |
| 3/31/2022 | RENAISSANCE TECHNOLOGIES LLC Bought 358.0 Thousand shares of Emergent BioSolutions Inc |
Top 10 Owners of Emergent BioSolutions Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BlackRock Fund Advisors | 15.49% | 7,816,293 | 253,091,567 | +258,599 | +3.42% |
| The Vanguard Group, Inc. | 10.05% | 5,071,598 | 164,218,343 | -200,391 | -3.80% |
| SSgA Funds Management, Inc. | 6.88% | 3,469,470 | 112,341,439 | +436,743 | +14.40% |
| EARNEST Partners LLC | 4.11% | 2,071,376 | 67,071,155 | -117,230 | -5.36% |
| Dimensional Fund Advisors LP | 2.71% | 1,368,661 | 44,317,243 | +342,964 | +33.44% |
| D. E. Shaw & Co. LP | 2.31% | 1,163,586 | 37,676,915 | +218,248 | +23.09% |
| Geode Capital Management LLC | 1.62% | 817,647 | 26,475,410 | -25,151 | -2.98% |
| Janus Henderson Investors US LLC | 1.55% | 783,894 | 25,382,488 | -1,038,987 | -57.00% |
| Invesco Capital Management LLC | 1.43% | 720,380 | 23,325,904 | -119,829 | -14.26% |
| Neuberger Berman Investment Advis... | 1.27% | 643,031 | 20,821,344 | -3,364 | -0.52% |
Top 10 Mutual Funds Holding Emergent BioSolutions Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| iShares Core S&P Small Cap ETF | 6.80% | 3,432,430 | 111,142,083 | 0 | 0.00% |
| SPDR S&P Biotech ETF | 3.25% | 1,640,846 | 53,130,593 | -529 | -0.03% |
| Vanguard Total Stock Market Index... | 2.67% | 1,348,383 | 43,660,642 | +2,574 | +0.19% |
| Vanguard Small Cap Index Fund | 2.27% | 1,147,364 | 37,151,646 | +3,171 | +0.28% |
| iShares Russell 2000 ETF | 2.13% | 1,074,549 | 34,793,897 | -2,208 | -0.21% |
| Janus Henderson Triton Fund | 1.84% | 927,472 | 30,031,543 | -500,410 | -35.05% |
| iShares S&P Small Cap 600 Value E... | 1.40% | 708,047 | 22,926,562 | +530 | +0.07% |
| Vanguard Small Cap Growth Index F... | 1.37% | 692,515 | 22,423,636 | -266 | -0.04% |
| Janus Henderson Small Cap Value F... | 1.28% | 645,269 | 20,893,810 | +187,699 | +41.02% |
| Vanguard Extended Market Index Fu... | 1.25% | 632,053 | 20,465,876 | -1,260 | -0.20% |